These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6141189)

  • 1. Patterns of psychotropic drug use and tardive dyskinesia.
    Branchey M; Branchey L
    J Clin Psychopharmacol; 1984 Feb; 4(1):41-5. PubMed ID: 6141189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G; Cole JO; Schniebolk S; Salomon M
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
    Ezrin-Waters C; Seeman MV; Seeman P
    J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and management of tardive dyskinesia.
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of tardive dyskinesia.
    Tepper SJ; Haas JF
    J Clin Psychiatry; 1979 Dec; 40(12):508-16. PubMed ID: 40964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic drugs: how to reduce the risk of tardive dyskinesia.
    DeVeaugh-Geiss J
    Geriatrics; 1979 Jul; 34(7):59-61, 66. PubMed ID: 36330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical aspects of tardive dyskinesias induced by neuroleptics].
    Villeneuve A; Lajeunesse C
    Encephale; 1988 Sep; 14 Spec No():209-14. PubMed ID: 2905648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occurrence of tardive dyskinesia during neuroleptic treatment].
    Fanget F; Henry E; Aimard G
    Presse Med; 1986 Dec; 15(43):2147-50. PubMed ID: 2884657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia and depressive illness.
    Davis KL; Berger PA; Hollister LE
    Psychopharmacol Commun; 1976; 2(2):125-30. PubMed ID: 10603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia and glucid metabolism.
    Brousse G; Meary A; Mouret J; Blanc O; Hueber T; Lemoine P; Llorca PM; Lachaux B
    Hum Psychopharmacol; 2007 Aug; 22(6):373-80. PubMed ID: 17579925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tardive dyskinesia. A possible complication of chronic treatment with neuroleptics].
    D'Aquila F; Rampello L
    Riv Neurol; 1990; 60(4):140-5. PubMed ID: 1982720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroleptic-induced movement disorders: historical perspectives].
    Wolf MA; Yassa R; Llorca PM
    Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive dyskinesia: characterization and prevalence in a statewide system.
    Bell RC; Smith RC
    J Clin Psychiatry; 1978 Jan; 39(1):39-47. PubMed ID: 580260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment with neuroleptics is not dangerous for the patient. The risk of tardive dyskinesia is increased in overdosing].
    Wiesel FA
    Lakartidningen; 1987 Sep; 84(40):3174-6. PubMed ID: 2890802
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients.
    Jeste DV; Lacro JP; Palmer B; Rockwell E; Harris MJ; Caligiuri MP
    Am J Psychiatry; 1999 Feb; 156(2):309-11. PubMed ID: 9989570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE; Kuskowski MA; Caligiuri MP
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between neuroleptic extrapyramidal syndromes and patients' all-cause mortality.
    Modestin J; Vogt Wehrli M; Stephan PL; Agarwalla P
    Pharmacopsychiatry; 2009 Mar; 42(2):57-60. PubMed ID: 19308879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia and plasma homovanillic acid.
    Moore DC; Glazer WM; Bowers MB; Heninger GR
    Biol Psychiatry; 1983 Dec; 18(12):1393-402. PubMed ID: 6140961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late onset involuntary movements in chronic schizophrenia: age-related vulnerability to 'tardive' dyskinesia independent of extent of neuroleptic medication.
    Waddington JL; Youssef HA
    Ir Med J; 1985 May; 78(5):143-6. PubMed ID: 2861172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.